Published in PLoS One on November 14, 2008
Consideration of postpartum management in HIV-positive Haitian women: an analysis of CD4 decline, mortality, and follow-up after delivery. J Acquir Immune Defic Syndr (2012) 1.62
Promising outcomes of a national programme for the prevention of Mother-to-Child HIV transmission in Addis Ababa: a retrospective study. BMC Health Serv Res (2010) 1.45
Mother-to-child transmission of HIV and its predictors among HIV-exposed infants at a PMTCT clinic in northwest Ethiopia. BMC Public Health (2013) 1.15
Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake. HIV Ther (2010) 0.94
Serologic imprint of dengue virus in urban Haiti: characterization of humoral immunity to dengue in infants and young children. Am J Trop Med Hyg (2011) 0.94
Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One (2014) 0.90
Growth in late infancy among HIV-exposed children in urban Haiti is associated with participation in a clinic-based infant feeding support intervention. J Nutr (2012) 0.84
Compliance with and outcomes of CD4-based national guidelines for prevention of mother-to-child transmission of HIV for Thailand, 2006-2007. Southeast Asian J Trop Med Public Health (2013) 0.82
Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option B. AIDS Res Treat (2016) 0.78
Outcomes and linkage to chronic care of HIV exposed infants among health centers and hospitals in Amhara Region, Ethiopia: implications to prevention of mother-to-child transmission of HIV program: a cross sectional study. Pan Afr Med J (2016) 0.75
Maternal HIV illness and its impact on children well-being and development in Haiti. J Child Fam Stud (2014) 0.75
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet (2004) 16.28
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet (1999) 8.98
Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med (2005) 8.13
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis (2004) 5.93
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 5.17
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet (1999) 5.00
Public health. Implementation science. Science (2007) 4.33
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet (2004) 4.25
Achievements in public health. Reduction in perinatal transmission of HIV infection--United States, 1985-2005. MMWR Morb Mortal Wkly Rep (2006) 3.27
Child mortality and HIV infection in Africa: a review. AIDS (2004) 3.02
Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS (2005) 2.97
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med (2007) 2.93
Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS (2003) 2.89
Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr (2006) 2.66
Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis (2007) 2.64
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep (2002) 2.26
The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000. J Acquir Immune Defic Syndr (2003) 2.18
International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol (2007) 1.82
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS (2008) 1.81
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr (2005) 1.57
Laboratory testing and rapid HIV assays: applications for HIV surveillance in hard-to-reach populations. AIDS (2001) 1.52
Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. MMWR Morb Mortal Wkly Rep (1998) 1.50
Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet (2003) 1.31
Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J (1999) 1.19
Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol (2007) 1.15
Association between low birth weight and infant mortality in children born to human immunodeficiency virus 1-infected mothers in Tanzania. Pediatr Infect Dis J (2004) 1.11
Prevention of mother-to-child transmission of HIV in Haiti. Rev Panam Salud Publica (2009) 1.06
Tale of two epidemics--the continuing challenge of preventing mother-to-child transmission of human immunodeficiency virus. J Infect Dis (2003) 1.06
Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti. J Clin Microbiol (2007) 1.01
Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076--results and treatment recommendations. Pediatr Infect Dis J (1995) 1.00
Contribution of bacterial sepsis to morbidity in infants born to HIV-infected Haitian mothers. J Acquir Immune Defic Syndr (2006) 0.98
Short course of AZT halves HIV-1 perinatal transmission. Lancet (1998) 0.80
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
The burden of respiratory syncytial virus infection in young children. N Engl J Med (2009) 8.95
Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med (2010) 8.72
The underrecognized burden of influenza in young children. N Engl J Med (2006) 8.25
Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med (2005) 8.13
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med (2004) 7.71
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med (2013) 6.60
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med (2011) 6.42
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med (2015) 6.04
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med (2015) 4.90
Comprehension during informed consent in a less-developed country. Lancet (2002) 4.46
Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis (2002) 4.22
Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol (2003) 4.19
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis (2005) 3.79
Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis (2001) 3.73
Rhinovirus-associated hospitalizations in young children. J Infect Dis (2007) 3.35
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol (2007) 3.22
Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med (2002) 3.02
Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis (2007) 2.64
Renal dysfunction among HIV-infected patients starting antiretroviral therapy. AIDS (2011) 2.56
A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol (2008) 2.53
Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health Organ (2005) 2.50
The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol (2006) 2.43
Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol (2004) 2.42
Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis (2008) 2.37
5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti. N Engl J Med (2009) 2.21
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis (2002) 2.19
The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000. J Acquir Immune Defic Syndr (2003) 2.18
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr (2009) 2.15
Simultaneous detection and high-throughput identification of a panel of RNA viruses causing respiratory tract infections. J Clin Microbiol (2007) 2.14
Influenza burden for children with asthma. Pediatrics (2008) 2.10
Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis (2010) 2.09
Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis (2002) 2.06
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis (2005) 2.02
National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics (2006) 2.01
High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis (2009) 1.93
Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr (2008) 1.93
Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis (2011) 1.93
Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ (2004) 1.90
Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis (2012) 1.84
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study. Lancet Infect Dis (2013) 1.83
Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics (2013) 1.83
Failure of routine diagnostic methods to detect influenza in hospitalized older adults. Infect Control Hosp Epidemiol (2010) 1.77
Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting. Clin Infect Dis (2010) 1.77
Trends in antibiotic prescribing for adults in the United States--1995 to 2002. J Gen Intern Med (2005) 1.75
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One (2010) 1.73
Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis (2011) 1.68
The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine (2007) 1.68
Emergence of parapneumonic empyema in the USA. Thorax (2011) 1.67
Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol (2006) 1.66
Burden of human metapneumovirus infection in young children. N Engl J Med (2013) 1.65
Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol (2003) 1.64
Consideration of postpartum management in HIV-positive Haitian women: an analysis of CD4 decline, mortality, and follow-up after delivery. J Acquir Immune Defic Syndr (2012) 1.62
A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med (2011) 1.61
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun (2004) 1.60
Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio Sublineage of the Latin American-Mediterranean Mycobacterium tuberculosis spoligotype family. J Clin Microbiol (2008) 1.59
Differences in antibiotic prescribing among physicians, residents, and nonphysician clinicians. Am J Med (2005) 1.58
Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis (2011) 1.54
Increasing women in leadership in global health. Acad Med (2014) 1.52
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. Bull World Health Organ (2008) 1.49
Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. Am J Trop Med Hyg (2011) 1.49
Do childhood vaccines have non-specific effects on mortality? Bull World Health Organ (2004) 1.46
Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med (2002) 1.43
Hypothalamic gene expression in ω-3 PUFA-deficient male rats before, and following, development of hypertension. Hypertens Res (2011) 1.43
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol (2009) 1.42
Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med (2007) 1.41
Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis (2013) 1.40
Epidemiology of HIV infection and risk in adolescents and youth. J Acquir Immune Defic Syndr (2010) 1.40
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics (2006) 1.38
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One (2010) 1.37
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Pediatrics (2006) 1.36
Removal of a single alpha-tubulin gene intron suppresses cell cycle arrest phenotypes of splicing factor mutations in Saccharomyces cerevisiae. Mol Cell Biol (2002) 1.36
Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness. J Clin Microbiol (2007) 1.34
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. Pediatr Infect Dis J (2003) 1.32
The use of an educational video during informed consent in an HIV clinical trial in Haiti. J Acquir Immune Defic Syndr (2006) 1.31